Literature DB >> 7418262

Radioconglutinin-binding azssay for circulating immune complexes: a new method.

K V Johny, M K Dasgupta, B Singh, J B Dossetor.   

Abstract

A new method for the detection of circulating immune complexes using radiolabelled conglutinin as a marker for complement-bound complexes precipitated in low concentrations (3.5%) of polyethylene glycol is described. The optimal laboratory conditions for the test have been defined and certain limitations studied. The technique is simple with good reproducibility and high degree of specificity. In a double-blind study of eighty-seven samples of sera from normals, patients with glomerulonephritis, post-renal transplantation, rheumatic diseases, breast tumours, multiple sclerosis and infections the method was compared and correlated to the Clq-binding assay and the Raji cell test. The radioconglutinin-binding assay was most discriminative for cases of glomerulonephritis, renel transplantation, breast carcinoma and multiple sclerosis and least for rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7418262      PMCID: PMC1538933     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  The nature of immune complexes in human cancer sera.

Authors:  A N Theofilopoulos; B S Andrews; M M Urist; D L Morton; F J Dixon
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

2.  Solid-phase enzyme immunoassay or radioimmunoassay for the detection of immune complexes based on their recognition by conglutinin: conglutinin-binding test. A comparative study with 125I-labelled Clq binding and Raji-cell RIA tests.

Authors:  P Casali; A Bossus; N A Carpentier; P H Lambert
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

Review 3.  Immune complex disease in experimental animals and man.

Authors:  C G Cochrane; D Koffler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

4.  Circulating immune complexes in inflammatory bowel disease.

Authors:  D P Jewell; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

Review 5.  Conglutinin and immunoconglutinins.

Authors:  P J Lachmann
Journal:  Adv Immunol       Date:  1967       Impact factor: 3.543

6.  Circulating immune complexes in normal human pregnancy.

Authors:  P L Masson; M Delire; C L Cambiaso
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

7.  Use of bovine conglutinin for the assay of immune complexes.

Authors:  R A Eisenberg; A N Theofilopoulos; F J Dixon
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

8.  Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.

Authors:  U E Nydegger; R H Zubler; R Gabay; G Joliat; C H Karagevrekis; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

9.  Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera.

Authors:  J Siegel; R Rent; H Gewurz
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

10.  Receptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance.

Authors:  A N Theofilopoulos; V A Bokisch; F J Dixon
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

View more
  1 in total

1.  Antibody-mediated cellular cytotoxicity against Raji cells ADCC(Raji): evaluation of false positives in the detection of circulating immune complexes by Raji-cell assay.

Authors:  M K Dasgupta; T Kovithavongs; J Schlaut; B M Longenecker; J B Dossetor
Journal:  J Clin Immunol       Date:  1982-07       Impact factor: 8.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.